Transtheoretical Model's Impact on Cardiac Rehabilitation in Acute Myocardial Infarction Patients
This study uses the Transtheoretical Model to understand how it can improve cardiac rehabilitation in people who have had an acute myocardial infarction. We will measure changes in exercise capacity, self-efficacy, and social support after 3 months of rehabilitation.
TTMCR
Treatment Study
Summary
Study start date: June 1, 2022
Actual date on which the first participant was enrolled.This study investigates the effectiveness of a special program for people who have had a heart attack, known as acute myocardial infarction (AMI). It involves a group of 86 patients who are split into two groups. One group receives a new type of care that includes personalized exercise plans, education tailored to their stage of recovery, and ongoing support from a team of healthcare professionals. The other group receives standard care without the extra structured follow-up. This study aims to see if the new program improves heart and lung function, confidence in exercising, and support for exercise compared to traditional methods. Participants in the new program are provided with a home-based exercise plan and support through phone calls, social media, and online consultations for 12 weeks. Their progress is measured by testing how their heart and lungs work during exercise and by checking their confidence and social support for exercising. The study also looks at how often participants exercise each week and any changes in their exercise habits. The goal is to understand if this comprehensive approach can lead to better recovery outcomes for heart attack patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.86 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location